BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 18755717)

  • 41. Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma.
    Valleron W; Ysebaert L; Berquet L; Fataccioli V; Quelen C; Martin A; Parrens M; Lamant L; de Leval L; Gisselbrecht C; Gaulard P; Brousset P
    Blood; 2012 Nov; 120(19):3997-4005. PubMed ID: 22990019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
    Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
    Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.
    Atallah-Yunes SA; Robertson MJ; Davé UP
    Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):659-665. PubMed ID: 35577752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.
    Piccaluga PP; Agostinelli C; Califano A; Rossi M; Basso K; Zupo S; Went P; Klein U; Zinzani PL; Baccarani M; Dalla Favera R; Pileri SA
    J Clin Invest; 2007 Mar; 117(3):823-34. PubMed ID: 17304354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
    Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
    Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis.
    Tolkachjov SN; Weenig RH; Comfere NI
    J Am Acad Dermatol; 2016 Nov; 75(5):992-999. PubMed ID: 27498959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
    Oluwasanjo A; Kartan S; Johnson W; Alpdogan O; Gru A; Mishra A; Haverkos BM; Gong J; Porcu P
    Cancer Treat Res; 2019; 176():83-98. PubMed ID: 30596214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Review of Current Disease Understanding and Therapeutic Approaches.
    Al-Zahrani M; Savage KJ
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):189-207. PubMed ID: 28340873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.
    Laginestra MA; Piccaluga PP; Fuligni F; Rossi M; Agostinelli C; Righi S; Sapienza MR; Motta G; Gazzola A; Mannu C; Sabattini E; Bacci F; Tabanelli V; Sacchetti CA; Barrese TZ; Etebari M; Melle F; Clò A; Gibellini D; Tripodo C; Inghirami G; Croce CM; Pileri SA
    Blood Cancer J; 2014 Nov; 4(11):259. PubMed ID: 25382608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Approach to nodal-based T-cell lymphomas.
    de Leval L
    Pathology; 2020 Jan; 52(1):78-99. PubMed ID: 31785821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peripheral T-cell lymphoma classification: the matter of cellular derivation.
    Piccaluga PP; Agostinelli C; Tripodo C; Gazzola A; Bacci F; Sabattini E; Pileri SA;
    Expert Rev Hematol; 2011 Aug; 4(4):415-25. PubMed ID: 21801133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA profiling in peripheral T-cell lymphoma, not otherwise specified.
    Lin Y; Chen WM; Wang C; Chen XY
    Cancer Biomark; 2017; 18(4):339-347. PubMed ID: 28128734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
    Niitsu N
    J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distinct morphologic, phenotypic, and clinical-course characteristics of indolent peripheral T-cell lymphoma.
    Hayashi E; Takata K; Sato Y; Tashiro Y; Tachiyama Y; Sawada-Kitamura S; Hiramatsu Y; Sugiguchi S; Nose S; Hirokawa M; Ando M; Abd Alkader L; Maeda Y; Tanimoto M; Yoshino T
    Hum Pathol; 2013 Sep; 44(9):1927-36. PubMed ID: 23706909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological analysis in PTCL-NOS with CADM1 expression.
    Kato T; Miyoshi H; Kobayashi S; Yoshida N; Imaizumi Y; Seto M; Uchimaru K; Miyazaki Y; Ohshima K
    Virchows Arch; 2017 Nov; 471(5):659-666. PubMed ID: 28940014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.
    Yamasaki S; Iida H; Yoshida I; Komeno T; Sawamura M; Matsumoto M; Sekiguchi N; Hishita T; Sunami K; Shimomura T; Takatsuki H; Yoshida S; Otsuka M; Kato T; Kuroda Y; Ooyama T; Suzuki Y; Ohshima K; Nagai H; Iwasaki H
    Leuk Lymphoma; 2021 Apr; 62(4):819-827. PubMed ID: 33167741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive.
    Agostinelli C; Hartmann S; Klapper W; Korkolopoulou P; Righi S; Marafioti T; Piccaluga PP; Patsouris E; Hansmann ML; Lennert K; Pileri SA
    Histopathology; 2011 Oct; 59(4):679-91. PubMed ID: 22014049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.